Holen Sie sich die Stockscreener-App
9.24
1.81%
-0.17
Handel nachbörslich:
9.24
Immatics N V Aktie (IMTX) Neueste Nachrichten
Immatics N.V. (IMTX) Seeing Strong Enrollment in a Key Phase 3 Trial of Drug Candidate - Yahoo Finance
Can Immatics NV Equity Warrant generate free cash flow2026 Market Sentiment & Target Return Focused Stock Picks - baoquankhu1.vn
Immatics (NASDAQ:IMTX) Sees Strong Trading VolumeHere's What Happened - MarketBeat
Immatics (NASDAQ:IMTX) Shares Gap DownTime to Sell? - MarketBeat
Is Immatics’ 2025 Loss and PRAME Pipeline Push Altering The Investment Case For Immatics (IMTX)? - simplywall.st
Jefferies Financial Group Inc. Takes $10.18 Million Position in Immatics N.V. $IMTX - MarketBeat
Insider Buy: What is the target price for Immatics NV stockDay Trade & Real-Time Volume Triggers - baoquankhu1.vn
Immatics: Buying The Anzu-Cel Floor, Playing The Moderna Moonshot (NASDAQ:IMTX) - Seeking Alpha
Immatics NV earnings beat by €0.13, revenue topped estimates - Investing.com Nigeria
Wall Street Zen Upgrades Immatics (NASDAQ:IMTX) to "Hold" - MarketBeat
Wall Street Zen Upgrades Immatics (NASDAQ:IMTX) to “Hold” - Defense World
Is Immatics N.V. Equity Warrant stock near bottom after declineGold Moves & Low Risk Growth Stock Ideas - Naître et grandir
Tech Rally: Should I invest in Immatics NV Equity Warrant before earnings2025 Momentum Check & Short-Term Swing Trade Alerts - baoquankhu1.vn
Immatics 2025 Financial Results: Q4 Revenue $23M, Annual Loss $222.2MNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Immatics (NASDAQ:IMTX) Announces Quarterly Earnings Results, Beats Expectations By $0.14 EPS - MarketBeat
Immatics Announces Full Year 2025 Financial Results and Business Update - Investing News Network
Immatics: Fourth Quarter Financial Overview - Bitget
Immatics: Q4 Earnings Snapshot - KVUE
Immatics (IMTX) Projects Promising Developments for 2026 After R - GuruFocus
Immatics Confirms 2027 Anzu-cel Launch Timeline as PRAME Franchise and Cash Runway Advance - TipRanks
Immatics Earnings Report: Q4 Overview - Benzinga
Immatics (NASDAQ: IMTX) 2025 results show revenue drop and larger net loss - Stock Titan
immatics biotechnologies GmbH (IMTXW) Competitors - Meyka
(IMTX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Immatics (NASDAQ:IMTX) Lowered to “Sell” Rating by Wall Street Zen - Defense World
IMTX SEC FilingsImmatics N.V 10-K, 10-Q, 8-K Forms - Stock Titan
Immatics (NASDAQ:IMTX) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Immatics N.V. (NASDAQ:IMTX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Trade Report: Is PACK a defensive stockWeekly Trading Summary & Advanced Technical Signal Analysis - baoquankhu1.vn
Energy Moves: Is Immatics NV in a long term uptrendPortfolio Risk Summary & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Immatics (NASDAQ:IMTX) Trading Down 5% – Here’s What Happened - Defense World
IMTX PE Ratio & Valuation, Is IMTX Overvalued - Intellectia AI
Is Immatics N.V. a defensive stockQuarterly Trade Report & High Accuracy Swing Entry Alerts - mfd.ru
Aug Gainers: Whats next for Immatics NV Equity Warrant stockTrade Analysis Report & AI Driven Stock Price Forecasts - baoquankhu1.vn
Wall Street Zen Upgrades Immatics (NASDAQ:IMTX) to Hold - MarketBeat
Immatics N.V. (IMTX): Investor Outlook Reveals an 85% Upside Potential Amidst Groundbreaking Cancer Therapies - DirectorsTalk Interviews
RTW INVESTMENTS, LP Increases Stake in Immatics NV - GuruFocus
Can Immatics N.V. Equity Warrant expand into new marketsEarnings Recap Report & Smart Swing Trading Techniques - mfd.ru
Can Immatics N.V. Equity Warrant reach resistance levels soonJuly 2025 Chart Watch & Risk Controlled Stock Pick Alerts - mfd.ru
Will Immatics N.V. (4A3) stock gain from green policiesBuy Signal & Reliable Momentum Entry Alerts - mfd.ru
Immatics (NASDAQ:IMTX) Shares Down 5%Time to Sell? - MarketBeat
Liquidity Mapping Around (IMTX) Price Events - Stock Traders Daily
Exit Recap: Is Immatics NV a cyclical or defensive stockPortfolio Gains Report & Real-Time Market Trend Scan - baoquankhu1.vn
RTW Investments reveals 8.5% Immatics N.V. (IMTX) stake in Schedule 13G/A - Stock Titan
Institution Moves: Is Flushing Financial Corporation attractive at current valuationQuarterly Performance Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
What Immatics (IMTX)'s Melanoma Orphan Drug Designation Means For Shareholders - Sahm
Immatics N.V. (IMTX) Stock Analysis: Near 93% Upside Potential Drives Investor Interest - DirectorsTalk Interviews
Does Immatics N.V. stock have upside surprise potentialQuarterly Earnings Report & Daily Technical Forecast Reports - mfd.ru
Can Immatics N.V. Equity Warrant be the next market leader2025 Key Highlights & Consistent Income Trade Ideas - mfd.ru
Immatics (IMTX) Receives FDA Orphan Status for Melanoma Treatmen - GuruFocus
Whale Trades: Will Immatics NV Equity Warrant benefit from government policyJuly 2025 News Drivers & Low Risk Entry Point Guides - baoquankhu1.vn
Pharma News: What is the target price for Immatics NV stockMarket Performance Summary & Expert Verified Movement Alerts - baoquankhu1.vn
Why (IMTX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Inflation Data: Is Immatics NV a cyclical or defensive stockQuarterly Trade Summary & Weekly High Return Forecasts - baoquankhu1.vn
Weekly Recap: Will Immatics NV Equity Warrant outperform its industry peersPortfolio Risk Report & Consistent Profit Alerts - baoquankhu1.vn
Is Immatics N.V. Equity Warrant stock undervalued vs historical averages2025 Key Lessons & Risk Controlled Swing Alerts - mfd.ru
Loss Report: Will Immatics N.V. Equity Warrant benefit from current market trends2025 Pullback Review & AI Forecasted Entry and Exit Points - baoquankhu1.vn
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):